Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin and Pemetrexed in High-Risk Stage I Lung Adenocarcinoma
NCT03380468Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Jan 2018
- Primary completion
- Jan 2024
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cisplatin micelle injection (HA132), pemetrexed in lung adenocarcinoma, sponsored by Fudan University. Started Jan 2018; status: recruiting.
02
Drugs
Cisplatin micelle injection (HA132)pemetrexed
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT03380468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380468.